| __timestamp | Ligand Pharmaceuticals Incorporated | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22570000 | 24518692 |
| Thursday, January 1, 2015 | 24378000 | 19886580 |
| Friday, January 1, 2016 | 26621000 | 12631689 |
| Sunday, January 1, 2017 | 28653000 | 21977998 |
| Monday, January 1, 2018 | 37734000 | 20759000 |
| Tuesday, January 1, 2019 | 41884000 | 20838000 |
| Wednesday, January 1, 2020 | 64435000 | 121812000 |
| Friday, January 1, 2021 | 57483000 | 152137000 |
| Saturday, January 1, 2022 | 70062000 | 83231000 |
| Sunday, January 1, 2023 | 52790000 | 122706000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, TG Therapeutics exhibited a remarkable growth in SG&A expenses, peaking in 2021 with a staggering 152 million, a 520% increase from 2014. In contrast, Ligand Pharmaceuticals showed a more stable trajectory, with expenses rising by approximately 133% over the same period, reaching their zenith in 2022. This divergence highlights TG Therapeutics' aggressive expansion strategy, while Ligand maintains a steady course. Such insights are invaluable for investors and industry analysts seeking to understand the financial strategies and market positioning of these pharmaceutical giants.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
Comparing SG&A Expenses: GSK plc vs Ligand Pharmaceuticals Incorporated Trends and Insights
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs TG Therapeutics, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated Trends and Insights
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Mesoblast Limited
Breaking Down SG&A Expenses: Ligand Pharmaceuticals Incorporated vs Novavax, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Xencor, Inc.